Clinical Trial Update: Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and tolerability for treating mild to moderate anxiety; no specific results or status are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Snippet

Sponsor: Ativus Farmaceutica Ltda | Conditions: Anxiety, Efficacy | Phase 3 | Status: UNKNOWN